Work

Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells

Year: 2011

Type: article

Source: Anti-Cancer Drugs

DOI: 10.1097/cad.0b013e32834e7d9b

Authors: Hye Jin Kim, Hwang-Phill Kim, Young-Kwang Yoon, Maeng-Sup Kim, Gwan-Sun Lee, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Do-Youn Oh, Yung-Jue Bang

Institutions: Hanmi Pharmaceutical (South Korea), Seoul National University, Seoul National University Hospital

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2015672298

FWCI: 0.324

Cites: 61

Cited by: 25

Related to: 10